These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 15990025)

  • 1. The calculated risk of fatal secondary malignancies from intensity-modulated radiation therapy.
    Kry SF; Salehpour M; Followill DS; Stovall M; Kuban DA; White RA; Rosen II
    Int J Radiat Oncol Biol Phys; 2005 Jul; 62(4):1195-203. PubMed ID: 15990025
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of intensity-modulated pelvic radiotherapy on second cancer risk in the postoperative treatment of endometrial and cervical cancer.
    Zwahlen DR; Ruben JD; Jones P; Gagliardi F; Millar JL; Schneider U
    Int J Radiat Oncol Biol Phys; 2009 Jun; 74(2):539-45. PubMed ID: 19427555
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Out-of-field photon and neutron dose equivalents from step-and-shoot intensity-modulated radiation therapy.
    Kry SF; Salehpour M; Followill DS; Stovall M; Kuban DA; White RA; Rosen II
    Int J Radiat Oncol Biol Phys; 2005 Jul; 62(4):1204-16. PubMed ID: 15990026
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of intensity-modulated radiotherapy on radiation-induced second malignancies.
    Ruben JD; Davis S; Evans C; Jones P; Gagliardi F; Haynes M; Hunter A
    Int J Radiat Oncol Biol Phys; 2008 Apr; 70(5):1530-6. PubMed ID: 18207670
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A review of the impact of photon and proton external beam radiotherapy treatment modalities on the dose distribution in field and out-of-field; implications for the long-term morbidity of cancer survivors.
    Palm A; Johansson KA
    Acta Oncol; 2007; 46(4):462-73. PubMed ID: 17497313
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intensity-modulated radiation therapy, protons, and the risk of second cancers.
    Hall EJ
    Int J Radiat Oncol Biol Phys; 2006 May; 65(1):1-7. PubMed ID: 16618572
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monte Carlo study shows no significant difference in second cancer risk between 6- and 18-MV intensity-modulated radiation therapy.
    Kry SF; Salehpour M; Titt U; White RA; Stovall M; Followill D
    Radiother Oncol; 2009 Apr; 91(1):132-7. PubMed ID: 19147246
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Uncertainty of calculated risk estimates for secondary malignancies after radiotherapy.
    Kry SF; Followill D; White RA; Stovall M; Kuban DA; Salehpour M
    Int J Radiat Oncol Biol Phys; 2007 Jul; 68(4):1265-71. PubMed ID: 17637398
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A planning comparison of dose patterns in organs at risk and predicted risk for radiation induced malignancy in the contralateral breast following radiation therapy of primary breast using conventional, IMRT and volumetric modulated arc treatment techniques.
    Johansen S; Cozzi L; Olsen DR
    Acta Oncol; 2009; 48(4):495-503. PubMed ID: 19169915
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of dose escalation on secondary cancer risk after radiotherapy of prostate cancer.
    Schneider U; Lomax A; Besserer J; Pemler P; Lombriser N; Kaser-Hotz B
    Int J Radiat Oncol Biol Phys; 2007 Jul; 68(3):892-7. PubMed ID: 17459608
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment and minimization of contralateral breast dose for conventional and intensity modulated breast radiotherapy.
    Burmeister J; Alvarado N; Way S; McDermott P; Bossenberger T; Jaenisch H; Patel R; Washington T
    Med Dosim; 2008; 33(1):6-13. PubMed ID: 18262117
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Experimental determination of peripheral doses for different IMRT techniques delivered by a Siemens linear accelerator.
    Wiezorek T; Voigt A; Metzger N; Georg D; Schwedas M; Salz H; Wendt TG
    Strahlenther Onkol; 2008 Feb; 184(2):73-9. PubMed ID: 18259698
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Major reduction of monitor units with the avoidance of leaf-sequencing step by direct aperture based IMRT optimisation.
    Seppälä J; Lahtinen T; Kolmonen P
    Acta Oncol; 2009; 48(3):426-30. PubMed ID: 18766997
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estimation of risk of radiation-induced carcinogenesis in adolescents with nasopharyngeal cancer treated using sliding window IMRT.
    Sharma SD; Upreti RR; Laskar S; Tambe CM; Deshpande DD; Shrivastava SK; Dinshaw KA
    Radiother Oncol; 2008 Feb; 86(2):177-81. PubMed ID: 18082906
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Measurements of secondary neutron dose from 15 MV and 18 MV IMRT.
    Howell RM; Ferenci MS; Hertel NE; Fullerton GD; Fox T; Davis LW
    Radiat Prot Dosimetry; 2005; 115(1-4):508-12. PubMed ID: 16381776
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Practical aspects of inverse-planned intensity-modulated radiation therapy for prostate cancer: a radiation treatment planner's perspective.
    Parker W; Patrocinio H
    Can J Urol; 2005 Jun; 12 Suppl 2():48-52. PubMed ID: 16018834
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison of out-of-field dose and its constituent components for intensity-modulated radiation therapy versus conformal radiation therapy: implications for carcinogenesis.
    Ruben JD; Lancaster CM; Jones P; Smith RL
    Int J Radiat Oncol Biol Phys; 2011 Dec; 81(5):1458-64. PubMed ID: 20950947
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is intensity-modulated radiotherapy better than conventional radiation treatment and three-dimensional conformal radiotherapy for mediastinal masses in patients with Hodgkin's disease, and is there a role for beam orientation optimization and dose constraints assigned to virtual volumes?
    Girinsky T; Pichenot C; Beaudre A; Ghalibafian M; Lefkopoulos D
    Int J Radiat Oncol Biol Phys; 2006 Jan; 64(1):218-26. PubMed ID: 16169675
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Study on surface dose generated in prostate intensity-modulated radiation therapy treatment.
    Chow JC; Grigorov GN; Barnett RB
    Med Dosim; 2006; 31(4):249-58. PubMed ID: 17134664
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peripheral neutron and gamma doses in radiotherapy with an 18 MV linear accelerator.
    Vanhavere F; Huyskens D; Struelens L
    Radiat Prot Dosimetry; 2004; 110(1-4):607-12. PubMed ID: 15353716
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.